For: | Purohit T, Cappell MS. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol 2015; 7(7): 926-941 [PMID: 25954476 DOI: 10.4254/wjh.v7.i7.926] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i7/926.htm |
Number | Citing Articles |
1 |
Johanna Schönau, Axel Wester, Jörn M. Schattenberg, Hannes Hagström. Risk of Cancer and Subsequent Mortality in Primary Biliary Cholangitis: A Population-based Cohort Study of 3052 Patients. Gastro Hep Advances 2023; 2(7): 879 doi: 10.1016/j.gastha.2023.05.004
|
2 |
Hatice Resorlu, Sevilay Kılıc, Selda Isık, Ferhat Gokmen. Successful infliximab therapy in a patient with comorbid spondyloarthritis, primary biliary cirrhosis and generalized morphea. Acta Clinica Belgica 2017; 72(5): 365 doi: 10.1080/17843286.2017.1290567
|
3 |
Fernando Crivellaro, Anselmo Costa, Pedro Vieira. Signal Quality in Continuous Transcutaneous Bilirubinometry. Sensors 2024; 24(18): 6154 doi: 10.3390/s24186154
|
4 |
E. Cebada Chaparro, J. Lloret del Hoyo, R. Méndez Fernández. Colangitis crónicas: diagnóstico diferencial y papel de la resonancia magnética. Radiología 2020; 62(6): 452 doi: 10.1016/j.rx.2020.08.004
|
5 |
Cornelia Thoeni, Catia T Perciani, Diana Nakib, Damra Camat, Ian D McGilvray, Sonya A MacParland, Sandra Fischer. Analysis of various ATP‐binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC). Histopathology 2023; 83(4): 559 doi: 10.1111/his.15006
|
6 |
Aleksandra Pavlovic Markovic, Milica Stojkovic Lalosevic, Dragana Danilo Mijac, Tamara Milovanovic, Sanja Dragasevic, Aleksandra Sokic Milutinovic, Miodrag N. Krstic. Jaundice as a Diagnostic and Therapeutic Problem: A General Practitioner’s Approach. Digestive Diseases 2022; 40(3): 362 doi: 10.1159/000517301
|
7 |
Xiao-Li Xiong, Yan Ding, Zhi-Lin Chen, Yao Wang, Pan Liu, Huan Qin, Li-Shan Zhou, Ling-Ling Zhang, Juan Huang, Lei Zhao. Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00522
|
8 |
Katia Sayaf, Daniela Gabbia, Francesco Paolo Russo, Sara De Martin. The Role of Sex in Acute and Chronic Liver Damage. International Journal of Molecular Sciences 2022; 23(18): 10654 doi: 10.3390/ijms231810654
|
9 |
Xueli Yang, Xianliang Hou, Junning Zhang, Zhenyu Liu, Guangyu Wang. Research progress on the application of single-cell sequencing in autoimmune diseases. Genes & Immunity 2023; 24(5): 220 doi: 10.1038/s41435-023-00216-9
|
10 |
|
11 |
Tiannan Zhou, Huixian Wei, Jinjun Wang, Sudhir Kumar Rai. Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid. PLOS ONE 2023; 18(2): e0279431 doi: 10.1371/journal.pone.0279431
|
12 |
Aurora Marina Loaeza-del Castillo, Alhely Gaytán-Santillán, Alma López-Tello, Merit Valdés-Almanza Merit, María del Pilar Milke-García, Jorge Flores-Rodríguez, Ulices Alvirde-García. Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis. Annals of Hepatology 2019; 18(6): 879 doi: 10.1016/j.aohep.2019.07.006
|
13 |
Cynthia Levy, Christopher L. Bowlus, Elizabeth Carey, Julie M. Crawford, Karen Deane, Marlyn J. Mayo, W. Ray Kim, Michael W. Fried. A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale. Hepatology Communications 2018; 2(5): 484 doi: 10.1002/hep4.1173
|
14 |
Ludovico Abenavoli, Anna Caterina Procopio, Pietro Cinaglia, Christian Zanza, Claudio Delle Grazie, Yaroslava Longhitano, Pavla Libicherova, Francesco Luzza. Clinical Patterns of Primary Biliary Cholangitis: Comparison Between
Two European Case Series. Reviews on Recent Clinical Trials 2022; 17(2): 136 doi: 10.2174/1574887117666220617095856
|
15 |
Yifei Yang, Bingqian Liu, Bo Zang, Qixuan Liu, Chenyang Zhao, Yuan Yao, Bin Liu. Autotaxin: A Potential biomarker for primary biliary cholangitis. Heliyon 2024; 10(1): e23438 doi: 10.1016/j.heliyon.2023.e23438
|
16 |
E. I. Khoroshavina, M. V. Dubinin, V. N. Samartsev. Ursodeoxycholic acid, in contrast to other bile acids, induces Ca2+-dependent cyclosporin A-insensitive permeability transition in liver mitochondria in the presence of potassium chloride. Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 2016; 10(4): 287 doi: 10.1134/S1990747816030144
|
17 |
Simon Zec, Dusan Popovic, Vera Matovic, Vladimir Nikolic, Ksenija Bojovic, Jasna Jovic, Ljiljana Markovic Denic, Tomica Milosavljevic, Tamara Alempijevic, Olivier Barbier. Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire. PLOS ONE 2017; 12(4): e0175697 doi: 10.1371/journal.pone.0175697
|
18 |
Kearse Kelly P. Ultraviolet fluorescent detection of elevated bilirubin in dried blood serum. Journal of Forensic Science and Research 2022; 6(1) doi: 10.29328/journal.jfsr.1001036
|
19 |
Esperance A. Schaefer, Lawrence S. Friedman. Schiff's Diseases of the Liver. 2017; : 1 doi: 10.1002/9781119251316.ch1
|
20 |
Yu Zhao, Zhenjie Yin, Huang Du, Kangming Huang, Fajing Zhang, Hongbin Chen. The latest research trends in primary biliary cholangitis: a bibliometric analysis. Clinical and Experimental Medicine 2022; 23(2): 347 doi: 10.1007/s10238-022-00825-0
|
21 |
Kabir V. Malkani, Arun B. Jesudian, Jean J. Luo, Emily A. Schonfeld. Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome. Clinics and Research in Hepatology and Gastroenterology 2023; 47(5): 102114 doi: 10.1016/j.clinre.2023.102114
|
22 |
Yichen Han, Zhen-Hua Bian, Si-Yu Yang, Cheng-Bo Wang, Liang Li, Yan-Qing Yang, Aftab A. Ansari, M. Eric Gershwin, Xiaofeng Zeng, Zhe-Xiong Lian, Zhi-Bin Zhao. Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.860311
|
23 |
Kailing Wang, Yong Li, Jianfeng Pan, Huifang He, Ziyi Zhao, Yiming Guo, Xiaomei Zhang. Noninvasive diagnosis of AIH/PBC overlap syndrome based on prediction models. Open Medicine 2022; 17(1): 1550 doi: 10.1515/med-2022-0526
|
24 |
Zhiyi Zhang, Jian Wang, Yun Chen, Yiguang Li, Li Zhu, Huali Wang, Yilin Liu, Jiacheng Liu, Shengxia Yin, Xin Tong, Xiaomin Yan, Yuxin Chen, Chuanwu Zhu, Jie Li, Yuanwang Qiu, Chao Wu, Rui Huang. A novel web-based online nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome. Journal of Translational Autoimmunity 2023; 7: 100215 doi: 10.1016/j.jtauto.2023.100215
|
25 |
Yinghao Chang, Changcun Guo, Guanya Guo, Zhou Yuan, Xinmin Zhou, Jingbo Wang, Zheyi Han, Yu Chen, Gui Jia, Ying Han. Erythrocyte count is associated with prognosis in Chinese patients with primary biliary cholangitis. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8446
|
26 |
Takako Saeki, Akihiro Nakajima, Tomoyuki Ito, Takuma Takata, Naofumi Imai, Kazuhiro Yoshita, Hideyuki Kabasawa, Hajime Yamazaki, Ichiei Narita. Tubulointerstitial nephritis and Fanconi syndrome in a patient with primary Sjögren’s syndrome accompanied by antimitochondrial antibodies: A case report and review of the literature. Modern Rheumatology 2018; 28(5): 897 doi: 10.3109/14397595.2016.1174422
|
27 |
Juan Hao, Tao Yang, Yang Zhou, Guo-Yuan Gao, Feng Xing, Yuan Peng, Yan-Yan Tao, Cheng-Hai Liu. Serum Metabolomics Analysis Reveals a Distinct Metabolic Profile of Patients with Primary Biliary Cholangitis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00944-9
|
28 |
Sydney Kusumoputro, Christian Au, Katie H. Lam, Nathaniel Park, Austin Hyun, Emily Kusumoputro, Xiang Wang, Tian Xia. Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance. Nanomaterials 2023; 14(1): 67 doi: 10.3390/nano14010067
|
29 |
AbdiGhani Ismail, Lindsey Kennedy, Heather Francis. Sex-Dependent Differences in Cholestasis. The American Journal of Pathology 2023; 193(10): 1355 doi: 10.1016/j.ajpath.2023.06.010
|
30 |
Meike Dirks, Kim Haag, Henning Pflugrad, Anita B. Tryc, Ramona Schuppner, Heiner Wedemeyer, Andrej Potthoff, Hans L. Tillmann, Kajetan Sandorski, Hans Worthmann, Xiaoqi Ding, Karin Weissenborn. Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. Journal of Viral Hepatitis 2019; 26(4): 422 doi: 10.1111/jvh.12979
|
31 |
Chen-Yi Liao, Chi-Hsiang Chung, Pauling Chu, Kuang-yu Wei, Tseng-Min Feng, Fu-Huang Lin, Chang-Huei Tsao, Chia-Chao Wu, Wu-Chien Chien, Carlos M. Isales. Increased risk of osteoporosis in patients with primary biliary cirrhosis. PLOS ONE 2018; 13(3): e0194418 doi: 10.1371/journal.pone.0194418
|
32 |
Amitkumar Patel, Anil Seetharam. Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics. Journal of Clinical and Experimental Hepatology 2016; 6(4): 311 doi: 10.1016/j.jceh.2016.10.001
|
33 |
Jonas Blomberg, Carl-Gerhard Gottfries, Amal Elfaitouri, Muhammad Rizwan, Anders Rosén. Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00229
|
34 |
Debashree Debasish Das, Nikita Sharma, Pooja A Chawla. Current trends and future perspectives in the treatment of PBC and PSC: A review. Health Sciences Review 2022; 5: 100065 doi: 10.1016/j.hsr.2022.100065
|
35 |
Isabell Nilsson, Jeremy Palmer, Eirini Apostolou, Carl-Gerhard Gottfries, Muhammad Rizwan, Charlotte Dahle, Anders Rosén. Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00108
|
36 |
Katriina Nemes, Fredrik Åberg, Helena Gylling, Helena Isoniemi. Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications. World Journal of Hepatology 2016; 8(22): 924-932 doi: 10.4254/wjh.v8.i22.924
|
37 |
Omer Shahab, Mehmet Sayiner, James Paik, Sean Felix, Pegah Golabi, Zobair M. Younossi. Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States. Hepatology Communications 2019; 3(3): 356 doi: 10.1002/hep4.1314
|
38 |
Naoto Fukunaga, Kenji Uryuhara, Tadaaki Koyama. Axillobifemoral Bypass for Aortitis Syndrome in a Living-Donor Liver Transplant Patient. Annals of Vascular Diseases 2016; 9(2): 114 doi: 10.3400/avd.cr.16-00016
|
39 |
Sheena Mago, George Y. Wu. Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review. Journal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00036
|
40 |
Maria Grazia Clemente, Fulvia Frau, Matilde Bernasconi, Maria Doloretta Macis, Lucia Cicotto, Giampaolo Pilleri, Stefano De Virgiliis, Paolo Castiglia, Patrizia Farci. Distinctive HLA‐II association with primary biliary cholangitis on the Island of Sardinia. United European Gastroenterology Journal 2017; 5(4): 527 doi: 10.1177/2050640616665030
|
41 |
Diana Ferreira, Cristiana Neto, José Lopes, Júlio Duarte, António Abelha, José Machado. Predicting the Survival of Primary Biliary Cholangitis Patients. Applied Sciences 2022; 12(16): 8043 doi: 10.3390/app12168043
|
42 |
Bogusław Okopień, Lukasz Buldak, Aleksandra Bołdys. Fibrates in the management of atherogenic dyslipidemia. Expert Review of Cardiovascular Therapy 2017; 15(12): 913 doi: 10.1080/14779072.2017.1408410
|
43 |
Marlyn J. Mayo, Paul J. Pockros, David Jones, Christopher L. Bowlus, Cynthia Levy, Imran Patanwala, Bruce Bacon, Velimir Luketic, Raj Vuppalanchi, Sharon Medendorp, Alejandro Dorenbaum, Ciara Kennedy, Patricia Novak, Joan Gu, George Apostol, Gideon M. Hirschfield. A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. Hepatology Communications 2019; 3(3): 365 doi: 10.1002/hep4.1305
|
44 |
André Jefremow, Markus F. Neurath. New agents for immunosuppression. Best Practice & Research Clinical Gastroenterology 2021; : 101763 doi: 10.1016/j.bpg.2021.101763
|
45 |
Katarzyna Trzos, Natalia Pydyn, Jolanta Jura, Jerzy Kotlinowski. Selected transgenic murine models of human autoimmune liver diseases. Pharmacological Reports 2022; 74(2): 263 doi: 10.1007/s43440-021-00351-y
|
46 |
Hao Chen, Xiaotao Huang, Jianbin Min, Weirong Li, Rong Zhang, Wei Zhao, Changhui Liu, Lang Yi, Suiqing Mi, Ningsheng Wang, Qi Wang, Chenchen Zhu. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2. Journal of Ethnopharmacology 2016; 179: 197 doi: 10.1016/j.jep.2015.12.033
|
47 |
Laurie Larson, Michelle James, Andrea Gossard. Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis. AACN Advanced Critical Care 2016; 27(4): 441 doi: 10.4037/aacnacc2016202
|
48 |
Yu-Ling Yan, Xian Xing, Yi Wang, Xiao-Ze Wang, Zhi Wang, Li Yang. Clinical utility of two-dimensional shear-wave elastography in monitoring disease course in autoimmune hepatitis-primary biliary cholangitis overlap syndrome. World Journal of Gastroenterology 2022; 28(18): 2021-2033 doi: 10.3748/wjg.v28.i18.2021
|
49 |
Ashaki D. Patel, Kimberly Katz, Kenneth B. Gordon. Cutaneous Manifestations of Chronic Liver Disease. Clinics in Liver Disease 2020; 24(3): 351 doi: 10.1016/j.cld.2020.04.003
|
50 |
宁 唐. Clinical Efficacy of Zoledronic Acid in the Treatment of Primary Biliary Cholangitis with Secondary Osteoporosis. Advances in Clinical Medicine 2020; 10(05): 775 doi: 10.12677/ACM.2020.105119
|
51 |
Dahyeon Lee, Jeong Seop Park, Doyoung Kim, Hyun Sook Hong. Substance P Hinders Bile Acid-Induced Hepatocellular Injury by Modulating Oxidative Stress and Inflammation. Antioxidants 2022; 11(5): 920 doi: 10.3390/antiox11050920
|
52 |
Cenk Zeki Fikret, Enver Avci, Nil İrem Ucgun, Busra Yildirim, Filiz Yildirim, Mevlut Hamaci. Macula, choroid and retinal nerve fiber layer optical coherence tomography biomarkers in liver dysfunction. Turkish Journal of Biochemistry 2023; 48(1): 39 doi: 10.1515/tjb-2022-0064
|
53 |
Ziyan Cai, Wenyan Li, Wei Jiang, Jixiao Zhu, Guoyue Zhong, Rongrui Wei, Zejing Mu, Gang Ren. Protective effect of the ethyl acetate fraction of Qinghai-Tibet Plateau medicinal plant Chrysosplenium axillare Maxim. against ANIT-induced cholestatic liver injury in mice. Phytomedicine Plus 2021; 1(3): 100076 doi: 10.1016/j.phyplu.2021.100076
|
54 |
Laura Giordano, Rossella Cacciola, Paola Barone, Veronica Vecchio, Maria Elisa Nasso, Maria Eugenia Alvaro, Sebastiano Gangemi, Emma Cacciola, Alessandro Allegra. Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations. Diagnostics 2024; 14(11): 1135 doi: 10.3390/diagnostics14111135
|
55 |
E. Cebada Chaparro, J. Lloret del Hoyo, R. Méndez Fernández. Chronic cholangitis: Differential diagnosis and role of MRI. Radiología (English Edition) 2020; 62(6): 452 doi: 10.1016/j.rxeng.2020.08.002
|
56 |
Eva Gijbels, Alanah Pieters, Kevin De Muynck, Mathieu Vinken, Lindsey Devisscher. Rodent models of cholestatic liver disease: A practical guide for translational research. Liver International 2021; 41(4): 656 doi: 10.1111/liv.14800
|
57 |
Mirna El Dirani, Julius M Nagaratnam, Samer Kholoki. Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report. Cureus 2022; doi: 10.7759/cureus.26830
|
58 |
Paschalis Chatzipantelis, Alexandra Giatromanolaki. Early histopathologic changes in primary biliary cholangitis: does ‘minimal change’ primary biliary cholangitis exist? A pathologist’s view. European Journal of Gastroenterology & Hepatology 2021; 33(12): e7 doi: 10.1097/MEG.0000000000001876
|
59 |
E. I. Khoroshavina, M. V. Dubinin, A. V. Khokhlov, V. N. Samartsev. Bile Acid-Induced Ca2+ Efflux from Liver Mitochondria as a Factor Preventing the Formation of Mitochondrial Pores. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 2018; 12(2): 128 doi: 10.1134/S1990747818020071
|
60 |
Dilyara Akberova, Ivan A. Kiyasov, Diana Abdulganieva, Alfiya Odintsova. Changes of Intestinal Permeability («Triple Sugar Test») in Patients with Primary Biliary Cholangitis. BioNanoScience 2022; 12(2): 405 doi: 10.1007/s12668-022-00944-8
|
61 |
Nermine A. Ehsan, Maha M. Elsabaawy, Dina M. Sweed, Esraa A. Karman, Eman Abdelsameea, Anwar A. Mohamed. Role of liver biopsy in management of liver diseases without hepatic nodules following end of the interferon era: experience of a tertiary referral center. Clinical and Experimental Medicine 2022; doi: 10.1007/s10238-022-00797-1
|
62 |
Sylvia Drazilova, Ingrid Babinska, Jakub Gazda, Monika Halanova, Martin Janicko, Branislav Kucinsky, Dominik Safcak, Dominika Martinkova, Lucia Tarbajova, Anna Cekanova, Peter Jarcuska. Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia. International Journal of Public Health 2020; 65(5): 683 doi: 10.1007/s00038-020-01391-6
|
63 |
Dan Han, Jiayi Liu, Erhu Jin, Wen He. Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. Japanese Journal of Radiology 2019; 37(5): 412 doi: 10.1007/s11604-019-00822-6
|
64 |
Sen Tao, Hong Zhang, Qiang Zhao, Huaien Bu, Hongwu Wang, Hui Guo. Correlation of vitamin�D with inflammatory factors, oxidative stress and T cell subsets in patients with autoimmune hepatitis. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8601
|
65 |
Dane Fritzsche, Amy Indorf, Abby Miske, Kalyan Banda. Exemestane induced cholestatic liver injury – A case report. Journal of Oncology Pharmacy Practice 2021; 27(4): 1029 doi: 10.1177/1078155220957726
|
66 |
Ahmed H AlWabel, Musthafa Peedikayil, Sulaiman AlNasser, Khalid AlHusaini, Othman AlHekail, Saleh A Alqahtani, Ibrahim H AlTraif, Hamad AlAshgar. Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia. Saudi Journal of Gastroenterology 2023; 29(2): 135 doi: 10.4103/sjg.sjg_445_21
|
67 |
Zhanyi Li, Bingliang Lin, Guoli Lin, Yuankai Wu, Yusheng Jie, Xiangyong Li, Brian Ko, Yutian Chong, Jian Luo, Olivier Barbier. Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis. PLOS ONE 2017; 12(6): e0178580 doi: 10.1371/journal.pone.0178580
|
68 |
David Jones, Marco Carbone, Pietro Invernizzi, Nicola Little, Frederik Nevens, Mark G. Swain, Philippe Wiesel, Cynthia Levy. Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology Communications 2023; 7(3): e0057 doi: 10.1097/HC9.0000000000000057
|
69 |
Mateen AHMAD, Shinawar Waseem ALI, Aneela HAMEED, Mamoona AMIR, Jawad ASHRAF, Muhammad Inam Afzal, Muhammad UMER, Suliman A. ALSAGABY, Muhammad AWAIS, Muhammad IMRAN, Sanaullah IQBAL, Aftab AHMED, Muhammad RIAZ. Functional potential of Aloe vera juice against CCl4 induced hepatotoxicity in animal model. Food Science and Technology 2023; 43 doi: 10.1590/fst.110321
|
70 |
Soumyadeep Mukherjee, Arpita Kar, Najma Khatun, Puja Datta, Avik Biswas, Subhasis Barik. Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures. Cells 2021; 10(8): 1917 doi: 10.3390/cells10081917
|
71 |
Sho Hasegawa, Masato Yoneda, Yusuke Kurita, Asako Nogami, Yasushi Honda, Kunihiro Hosono, Atsushi Nakajima. Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents. Drugs 2021; 81(10): 1181 doi: 10.1007/s40265-021-01545-7
|
72 |
Agnieszka Kempinska-Podhorodecka, Monika Adamowicz, Mateusz Chmielarz, Maciej K. Janik, Piotr Milkiewicz, Malgorzata Milkiewicz. Vitamin-D Receptor-Gene Polymorphisms Affect Quality of Life in Patients with Autoimmune Liver Diseases. Nutrients 2020; 12(8): 2244 doi: 10.3390/nu12082244
|
73 |
Kriti Pandey, Debabrata Dash, Raj Kumar Koiri. Liver lobes and cirrhosis: Diagnostic insights from lobar ratios. Gastroenterology & Endoscopy 2024; doi: 10.1016/j.gande.2024.10.002
|
74 |
Cornelia Thoeni, Ruediger Waldherr, Jutta Scheuerer, Stefanie Schmitteckert, Ralph Roeth, Beate Niesler, Ernest Cutz, Christa Flechtenmacher, Benjamin Goeppert, Peter Schirmacher, Felix Lasitschka. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/1085717
|
75 |
Aya Hammami, Khouloud Ben Abdessalem, Sarra Mestiri, Nour Elleuch, Wafa Dahmani, Wafa Ben Ameur, Mehdi Ksiaa, Aida Ben Slama, Salem Ajmi, Ahlem Braham, Hanen Jaziri, Ali Jmaa. Case Report: Acute presentation of autoimmune hepatitis in a male patient. F1000Research 2021; 10: 406 doi: 10.12688/f1000research.52027.1
|
76 |
Abdulrahman Ismaiel, Vera Ciornolutchii, Thelva Esposito Herrera, Mohamed Ismaiel, Daniel‐Corneliu Leucuta, Stefan‐Lucian Popa, Dan L. Dumitrascu. Adiponectin as a biomarker in liver cirrhosis—A systematic review and meta‐analysis. European Journal of Clinical Investigation 2024; doi: 10.1111/eci.14328
|
77 |
Fan Yang, Yao Wang, Gang Li, Juan Xue, Zhi‐Lin Chen, Feng Jin, Lei Luo, Xuan Zhou, Qian Ma, Xin Cai, Hua‐Rong Li, Lei Zhao. Effects of corilagin on alleviating cholestasis via farnesoid X receptor‐associated pathways in vitro and in vivo. British Journal of Pharmacology 2018; 175(5): 810 doi: 10.1111/bph.14126
|